Central action beta‐blockers versus placebo for neuroleptic‐induced acute akathisia
Akathisia is recognised as one of the most common and distressing of the early‐onset adverse effects of neuroleptic drugs. This movement disorder is characterised by a subjective report of inner restlessness, mental unease or dysphoria, which can be intense. 
This review highlights the limited evidence available to support the use of central action beta‐blockers for neuroleptic‐induced acute akathisia. 
